Cargando…
Race and ethnicity do not impact eligibility for remdesivir: A single-center experience
As the Coronavirus-2019 (COVID-19) pandemic continues, multiple therapies are rapidly being evaluated for efficacy in clinical trials. Clinical trials should be racially and ethnically representative of the population that will eventually benefit from these medications. There are multiple potential...
Autores principales: | Pischel, Lauren, Walelo, Makeda, Benson, Jemma, Osborn, Rebecca, Schrier, Rachel, Tuan, Jessica, Barakat, Lydia, Ogbuagu, Onyema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101938/ https://www.ncbi.nlm.nih.gov/pubmed/33956849 http://dx.doi.org/10.1371/journal.pone.0250735 |
Ejemplares similares
-
599. Expanding HIV Training in Internal Medicine Residency Program: A Prospect to Meet the HIV Workforce Demand
por: Barakat, Lydia, et al.
Publicado: (2018) -
HIV risk profile and prevention needs of individuals seeking monkeypox (mpox) vaccination in an urban clinic in the U.S.: a brief report
por: Ogbuagu, Onyema, et al.
Publicado: (2023) -
Correction: HIV risk profile and prevention needs of individuals seeking monkeypox (mpox) vaccination in an urban clinic in the U.S.: a brief report
por: Ogbuagu, Onyema, et al.
Publicado: (2023) -
Eligibility for Human Leukocyte Antigen–Based Therapeutics by Race and Ethnicity
por: Olivier, Timothée, et al.
Publicado: (2023) -
1328. Post-War and Post-Ebola HIV Care Continuum in a Liberian Academic Center: Fresh Insights and Trends Over 5-Year Period
por: Watchekwa, Ian, et al.
Publicado: (2019)